Showing 5021-5030 of 8625 results for "".
- With Fibrocell Acquisition, Castle Creek Expands Late-Stage EB Pipelinehttps://practicaldermatology.com/news/with-fibrocell-acquisition-castle-creek-expands-late-stage-eb-pipeline/2460149/Castle Creek Pharmaceutical Holdings, Inc. acquired Fibrocell Science, Inc., a cell and gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases. With the resources of CCP Holdings’ subsidiary,
- Skin Cancer Foundation Website Has a New Lookhttps://practicaldermatology.com/news/skin-cancer-foundation-website-has-a-new-look/2460148/The Skin Cancer Foundation’s website has a new look. The site is redesigned to ease navigation and provide visitors with an improved user experience. Nearly 9 million people visit SkinCancer.org annually, and the organization say
- SENTÉ Partners with Scientis to Introduce Cysperahttps://practicaldermatology.com/news/sente-partners-with-scientis-to-introduce-cyspera/2460146/SENTÉ is partnering with Scientis, a Swiss dermatology company dedicated to developing novel dermo-cosmetic solutions to address skin pigmentation concerns, to introduce Cyspera®. Cyspera, a physician exclusive skincare product, is a novel intensive
- Dr. Richard M. Goldfarb Named Medical Director of DBM Corporationhttps://practicaldermatology.com/news/dr-richard-m-goldfarb-named-medical-director-ofdbm-corporation/2460145/Richard M. Goldfarb MD, is the new Medical Director of DBM Corporation Inc. is the official US representative of MIRACU PDO Threads. In this role, Dr. Goldfarb, the founder of the Center for SmartLipo & Plastic Surgery in the Philadelphia
- Skin Cancer Foundation Champions for Change Gala Coming in Octoberhttps://practicaldermatology.com/news/skin-cancer-foundation-champions-for-change-gala-coming-in-october/2460142/The Skin Cancer Foundation’s annual Champions for Change Gala comes to The Plaza New York City October 17. The Champions for Change Gala is the signature fundraising event for The Skin Cancer Foundation’s programs and initiatives. Awards a
- Newly Created Lancer Endowed Chair of Dermatology Honors Dr. Richard Rox Andersonhttps://practicaldermatology.com/news/newly-created-lancer-endowed-chair-of-dermatology-honors-dr-richard-rox-anderson/2460141/The inaugural Lancer Endowed Chair of Dermatology at Massachusetts General Hospital (MGH) is Richard Rox Anderson, MD, director of the MGH Wellman Center for Photomedicine. The Lancer Endowed Chair was announced on Sep. 4, 2019 by Harold Lancer, MD at the Paul S. Russell,
- Innovations In Skin Of Color Dermatology Award Presented to Dr. Andrew F. Alexishttps://practicaldermatology.com/news/innovations-in-skin-of-color-dermatology-award-presented-to-dr-andrew-f-alexis/2460140/The Journal of Drugs in Dermatology (JDD) presented dermatologist Andrew F. Alexis, MD, MPH, with the Innovations in Skin of Color Dermatology Award at Skin of Color Update, formerly Skin of Color Seminar Series, held September 7 and 8 in New York. The award recognizes individuals who ha
- Melanoma Research Alliance Awards Inaugural Cohort of Nine Dermatology Research Fellowshttps://practicaldermatology.com/news/melanoma-research-alliance-awards-inaugural-cohort-of-nine-dermatology-research-fellows/2460139/In recognition of the critical role dermatologists can play in the prevention and early detection of melanoma, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, announced the inaugural cohort of nine dermatology research fellows. The fellows, whic
- DermTech Closes Combination with Constellation Alpha Capital Corphttps://practicaldermatology.com/news/dermtech-closes-combination-with-constellation-alpha-capital-corp/2460138/DermTech, Inc., a precision dermatology company enabled by a non-invasive skin genomics platform, has completed its previously announced business combination with Constellation Alpha Capital Corp., a publicly traded special purpose acquisition company prior to the business combination. As a resul
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://practicaldermatology.com/news/fda-approves-juvederm-voluma-xc-for-mid-face-injection-via-cannula/2460137/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p